MedKoo Biosciences: CC-8890

This agent is not in stock, which may be available through custom synthesis. To inquire quotation and lead time or to ask questions, please send email to sales@medkoo.com to describe your needs. A representative will respond your email shortly. We offer big discount for orders of bulk quantities.

Quality control data:

Product will be shipped with supporting analytical data.

Information about this agent

CC-8490 is A benzopyran with potential antineoplastic activity. CC-8490 acts as a selective estrogen receptor modulator (SERM), inhibiting the proliferation of estrogen-sensitive breast cancer cells. This agent also inhibits growth and induces apoptosis of glioblastoma cells via a mechanism independent of estrogen receptor-related mechanisms. Check for active clinical trials or closed clinical trials using this agent. (NCI Thesaurus)

Current developer: Celgene Corporation

References

1: Hui AM, Zhang W, Chen W, Xi D, Purow B, Friedman GC, Fine HA. Agents with selective estrogen receptor (ER) modulator activity induce apoptosis in vitro and in vivo in ER-negative glioma cells. Cancer Res. 2004 Dec 15;64(24):9115-23. PubMed PMID: 15604281.

Contact MedKoo:

Email: sales@medkoo.com

(Keyword; CAS#; MedKoo code#)